Brampton, Ontario,
Canada -- August 10, 2022 -- InvestorsHub NewsWire
-- Galileo Life Sciences Inc.
(OTC
Pinksheet: Symbol: MDRM, also known as Modern Mobility Aids
Inc): ("Galileo or the "Company"), is a tech- enabled, healthcare
service provider in Ontario, on a mission to make healthcare
simple, accessible, and efficient for everyone. The Company's
platform bridges gaps in the healthcare ecosystem through
technology and innovation, providing easy access to primary-care
physicians through its virtual walk-in clinics located in
pharmacies for a one-stop medical visit by patients.
Galileo Life
Sciences (Canada) Inc, a division of Galileo Life Science Inc
(Nevada) currently has three clinics operating in the Toronto metro
area with a plan to have twenty-five clinics operational by end of
2022. The Company has an agreement with 2542153 Ontario Inc, to
provide licensed physicians trained in virtual care to Galileo
clinics.
"Virtual-Care and
digital health technology can be an effective tool to provide
patients access to high-quality care and we are pleased to continue
executing against our business model into 2022," said Tito DiMarco,
CEO of Galileo Life Sciences Inc., "Our agreement with 2542153 to
provide primary-care practitioners and specialists referrals to our
patients is a great achievement for the Company and it has enabled
the company to start generating revenue" "Over the past six months,
Galileo has seen transformative growth and we are very focused on a
pathway to expansion and profitability".
•
The vision of
Galileo Life Sciences Inc is to expand globally and provide
healthcare providers worldwide the technology and training in
virtual care so that they may access patients in remote areas in
their respective countries.
•
Unlike most
telehealth platforms, which offer only video calls with a
physician, who is unable to
examine the
patient, The Galileo Smart Clinics platform enables the physicians
to examine the patient virtually in real-time, thus providing
high-quality care.
•
The healthcare
providers can:
•
Capture data from
integrated medical devices in real-time
•
Review test
results
•
Exchange
documents
•
Provide necessary
care and prescriptions.
Patients can book
appointments using the Company's website www.galileolife.com or
walk into a clinic for a quick consultation.
About
Galileo Life Sciences Inc.
Galileo Life
Sciences Inc. (Formerly known as Modern Mobility Aids Inc) is a
company strategically focused on the telehealth and telemedicine
industry. The company is dedicated to offering the most robust
telehealth platform incorporating AI and IOT so that anyone can get
access to quality healthcare regardless of location and financial
status. The company is committed to providing access to healthcare
to everyone. With the company's services, physicians can get direct
access to the patient's vitals and examine the patient in real-time
without affecting the quality of care.
Forward-looking
Statements
This press release
may contain information that may constitute "forward-looking
information" or "forward-looking statements" within the meaning of
applicable Canadian and U.S. securities laws (collectively,
"Forward-looking Statements"). All information contained herein
that is not clearly historical in nature may constitute
Forward-looking Statements. In some cases, Forward- looking
Statements can be identified using forward-looking terminology such
as "may", "will", "expect", "plan", "anticipate", "intend",
"potential", "estimate", "believe" or the negative of these terms,
or other similar expressions intended to identify Forward-looking
Statements. There are no guarantees or assurances that expansion in
leadership will result in the hopes the company has mentioned here.
Any investment made into Modern Mobility Aids, Inc., would be
classified as speculative and risky. Such risks and uncertainties
include, but are not limited to: market conditions, general
acceptance of the company's products and technologies, competitive
factors, the ability to successfully complete additional or
adequate financing, government approvals or changes to proposed
laws, and other risks and uncertainties further stated in the
company's financial reports and filings. Any Forward-looking
Statement included in this press release is made as of the date of
this press release and, except as required by law, Galileo Life
Sciences Inc. and Modern Mobility Aids Inc. disclaim any obligation
to update or revise any Forward-looking Statement. Readers are
cautioned not to put undue reliance on any Forward- looking
Statement.
Contact
Tito
DiMarco
President tdimarco@mdrminc.com
+1 416 254 2581